Methods of generating and screening for lytic chimeric polypeptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10301607
APP PUB NO 20160137993A1
SERIAL NO

15001455

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonization and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HYPHARM GMBH82347 BERNRIED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Buchberger, Bernd Zeitlarn/Laub, DE 22 62
Molinaro, Sonja Weilheim, DE 12 9
Scherzinger, Anna Bernried, DE 5 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 28, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 28, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00